TABLE 1.
Main functions of ABC transporters involved in Aβ efflux.
| ABC transporter | Functions | Regulation | Expression in AD brain |
| ABCA1 | Transfer of cholesterol, other lipids to apoE | LXRs | Decreased |
| ABCA7 | Transfer of phospholipids to HDL; mediates macrophage, microglial phagocytosis | SREBP2 pathway | Increased; gene variants are risk factors for LOAD |
| ABCB1 (p-gp) | Efflux of xenobiotic substances from cells; works with LRP1 to promote Aβ efflux across BBB | Nuclear receptors (RXR, PXR, PPAR, others), inflammation, oxidative stress, receptor tyrosine kinases, growth factors | Decreased |
| ABCC1 | Efflux of xenobiotics, organic anions, glutathione | Notch1, transcription factors (GC elements, E-box elements) | Unclear; increased in AD mouse models |
| ABCC5 | Efflux of nucleoside/nucleotide analogs, glutamate analogs, cAMP, cGMP | Forkhead box M1, dexamethasone, human chorionic gonadotropin | Unknown; activity decreased in vitro after exposure of endothelial cells to Ab42 |
| ABCG1 | Transfers cholesterol to HDL, phospholipid vesicles, lipidated apoE | LXR, PPAR activators, RXR agonists | Unknown; ABCG1 SNPs reported to be AD risk factors |
| ABCG2 | Transport of xenobiotics | Inflammatory cytokines, dexamethasone, hypoxia, hormones, growth factors, gene amplification, epigenetic regulation | Conflicting reports |
| ABCG4 | Efflux of cholesterol and desmosterol to HDL | LXRs | Increased in AD plaque-associated microglia |
AD, Alzheimer’s disease; ApoE, apolipoprotein E; BBB, blood brain barrier; cAMP, cyclic adenosine monophosphate; cGMP, cyclic guanosine monophosphate; HDL, high density lipoproteins; LOAD, late onset Alzheimer’s disease; LRP1, low density lipoprotein receptor-related protein 1; LXR, liver X receptor; PPAR, peroxisome proliferator–activated receptor; PXR, pregnane X receptor; RXR, retinoid X receptor; SNP, single nucleotide polymorphism; SREBP2, sterol regulatory element-binding protein 2.